Series Objectives:

This activity provides oncology teams a platform to discuss implementation of personalized medicine for cancer patients in a tumor board format which includes patient case discussions focused on complex genetic information, extensive tumor sequencing such as whole-exome and whole-genome sequencing.

Series Target Audience: 

Adult and Pediatric Hematology and Oncology physicians, surgeons, research, and biorepository team members 

Series Contacts:
Nurse Practitioner, Director of Cancer Research:  Julie Martin, DNP, julie.martin@prismahealth.org

Medical Director: Ki Chung, MD, ki.chung@prismahealth.org